| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/23/1993 | EP0547654A1 Contrast agents for ultrasound imaging |
| 06/23/1993 | EP0547126A1 Polymers containing diester units. |
| 06/23/1993 | EP0547076A1 Cd58-specific monoclonal antibodies and their use |
| 06/23/1993 | EP0247156B1 Polychelating agents for image and spectral enhancement (and spectral shift) |
| 06/22/1993 | US5221485 Removal of low molecular weight impurities |
| 06/16/1993 | EP0546939A1 Biodegradable magnetic microclusters and methods for making them |
| 06/16/1993 | EP0352295B1 Biodadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents |
| 06/16/1993 | CN1073104A Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media |
| 06/16/1993 | CN1021257C Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 06/15/1993 | US5219764 Hapten-biotin conjugates and their use |
| 06/15/1993 | US5219740 Genetic engineering for mammalian implants |
| 06/15/1993 | US5219653 Sheet for assisting in nmr diagnosis |
| 06/15/1993 | US5219564 Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
| 06/15/1993 | US5219554 NMR imaging; diagnosis |
| 06/15/1993 | US5219553 Magnetic resonance imaging contrast media |
| 06/15/1993 | US5219552 Compositions intended for use in tomo densitometry |
| 06/15/1993 | US5219538 Gas and oxygen carrying lipid vesicles |
| 06/14/1993 | CA2084970A1 Biodegradable magnetic microclusters and methods for making them |
| 06/10/1993 | WO1993011147A1 Dna encoding a human 5-ht1e receptor and uses thereof |
| 06/10/1993 | WO1993011120A1 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
| 06/10/1993 | WO1993011098A1 Fluorinated compounds as oxygen transport agents |
| 06/10/1993 | WO1993010887A1 Purification of crude ioversol using reverse osmosis |
| 06/10/1993 | WO1993010825A1 Nonionic x-ray contrast agents, compositions and methods |
| 06/10/1993 | WO1993010824A1 Novel macromolecular polyamine iodine-containing compound, process for its preparation and its use as a contrast agent |
| 06/10/1993 | WO1993010821A1 A method and formulations useful to improve the study of human body cavities |
| 06/10/1993 | WO1993010743A2 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 06/10/1993 | CA2125188A1 New polyaminated iodated macromolecular compound, preparation process of the same and utilization as contrast agent |
| 06/10/1993 | CA2124561A1 Purification of crude ioversol using reverse osmosis |
| 06/10/1993 | CA2124559A1 Nonionic x-ray contrast agents, compositions and methods |
| 06/10/1993 | CA2101162A1 Dna encoding a human 5-ht1e receptor and uses thereof |
| 06/09/1993 | EP0545511A2 Process for the preparation of mono-N-substituted tetraazamacrocycles |
| 06/09/1993 | EP0544657A1 Method for making uniformly-sized particles from insoluble compounds |
| 06/08/1993 | US5217714 Administering interleukins, then measuring blood concentration of adrenocortocotropic hormones, glucocorticoids or other hormones |
| 06/08/1993 | US5217706 Contrast, solubility |
| 06/05/1993 | CA2084432A1 Contrast agents for ultrasound imaging |
| 06/02/1993 | EP0544412A2 Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| 06/02/1993 | EP0543872A1 New use of complex salts |
| 06/02/1993 | EP0369000A4 Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
| 06/02/1993 | CN1072593A Emulsions containing alkyl-or alkylglycerophosphoryl choline surfactants and methods of use |
| 06/01/1993 | US5215680 Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles |
| 06/01/1993 | CA1318668C Radioiodine benzodiazepine derivatives |
| 05/27/1993 | WO1993010440A1 Gel particle contrast media for improved diagnostic imaging |
| 05/27/1993 | WO1993010232A1 Lymphoid cd30-antigen |
| 05/27/1993 | WO1993010215A1 Purified proteoglycan betaglycan, compositions, and methods |
| 05/27/1993 | WO1993010078A1 New non ionic iodized agents for x-ray contrasting method for preparing them and galenical compositions containing them |
| 05/27/1993 | WO1993009814A1 Cocaine receptor binding ligands |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009787A1 Emulsions containing alkyl- or alkylgylcerophosphoryl choline surfactants and methods of use |
| 05/27/1993 | WO1993009762A2 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2123486A1 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 05/27/1993 | CA2121681A1 Gel particle contrast media for improved diagnostic imaging |
| 05/27/1993 | CA2121502A1 Emulsions containing alkyl-or alkylglycerophosphoryl choline surfactants and methods of use |
| 05/26/1993 | EP0543482A1 Aminocarboxylate ligands having substituted aromatic amide moieties |
| 05/26/1993 | EP0543454A2 Encapsulated particles useful as contrast agents in ultrasound and X-ray imaging compositions and methods |
| 05/26/1993 | EP0543020A1 Oxidized composite comprising water-soluble carboxypolysaccharide and magnetic iron oxide |
| 05/26/1993 | EP0542920A1 Cannabinoid receptor |
| 05/26/1993 | EP0542829A1 Method for producing magnetic microparticles from metallocenes. |
| 05/26/1993 | EP0420880B1 A method for the visual display of tumors using monoclonal antibodies |
| 05/26/1993 | EP0389543B1 Ultrasonic or shock wave operating process and agent for implementing said process |
| 05/25/1993 | US5213804 Localized delivery of antibiotic to tumor via bloodstream, encapsulation in liposome |
| 05/25/1993 | US5213788 Chromium complex associated with heparin |
| 05/22/1993 | CA2083109A1 Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods |
| 05/19/1993 | WO1993010079A1 New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them |
| 05/19/1993 | EP0542216A1 Diaminomercapto (thio)ethers as complexing agents for nucleides applicable in nuclear medicine, process for the preparation of this complexes, and masking kits containing them |
| 05/19/1993 | EP0541719A1 New carbohydrate-based anti-inflammatory agents |
| 05/19/1993 | EP0541704A1 ASSAY, METHODS AND PRODUCTS BASED ON $i(n) K?+ CHANNEL EXPRESSION |
| 05/19/1993 | CA2100338A1 Non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them |
| 05/18/1993 | US5212290 Monoclonal and polyclonal antibodies |
| 05/18/1993 | US5211938 Method of detection of malignant and non-malignant lesions by photochemotherapy of protoporphyrin IX percursors |
| 05/18/1993 | US5211937 Method of determining a site of inflammation utilizing elam-1 ligands |
| 05/18/1993 | CA1317937C Gadolinium chelates with carboxymethyl derivatives of polyazamacrocycles as nmr contrast agents |
| 05/13/1993 | WO1993008846A1 Contrast media |
| 05/13/1993 | WO1993008839A1 Multifunctional ligands for potential use in the design of therapeutic or diagnostic radiopharmaceutical imaging agents |
| 05/13/1993 | WO1993008833A1 A mammalian model system and methods of testing prophylaxis of fetal infection by hiv-1 or other lentiviruses |
| 05/13/1993 | DE4200043A1 Recombinant CD30 antigen (KI-1) and corresp. nucleic acid - for diagnosis of anaplastic large-cell lymphoma, and for prepn. of antibodies and antisera, in immuno-absorption, etc. |
| 05/13/1993 | CA2122726A1 Multifunctional ligands for potential use in the design of therapeutic or diagnostic radiopharmaceutical imaging agents |
| 05/12/1993 | EP0540975A1 Diethylenetriamine derivatives and their use for diagnostic and therapeutic purposes |
| 05/12/1993 | EP0540612A1 Heterobifunctional reagents and conjugates with oxaalkylene units for amphiphilic bridge structures |
| 05/12/1993 | EP0160670B1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 05/12/1993 | CN1071928A Rhenium and technetium complexes containing hypoxia-localizing moiety |
| 05/12/1993 | CN1071914A Complex salts of hematoporphyrin and of its derivatives, their synthesis, and therapeutic agent |
| 05/11/1993 | US5210300 Passing through mixed resin bed contained between cation and anion permeable membranes, applying electrical current to membranes; purification of crude intermediates of ioversol and 5-amino-N,N'-bis-/dihydroxypropyl/-triiodoisophthalamide waste |
| 05/11/1993 | US5210290 NMR diagnostic aid |
| 05/11/1993 | US5209720 Methods for providing localized therapeutic heat to biological tissues and fluids using gas filled liposomes |
| 05/07/1993 | CA2082023A1 Diethylenetriamine derivatives and their use for diagnostic and therapeutic purposes |
| 05/06/1993 | DE4136769A1 Tumorous tissue diagnosis - using fluorescent material with photosensitisers to show difference between healthy and affected tissue |
| 05/05/1993 | EP0539960A2 Hematoporphyrin derivatives complex salts and their use in the detection and treatment of neoplasms |
| 05/05/1993 | EP0539432A1 Diagnostic compositions for assessment of pancreatic insufficiency |
| 05/04/1993 | US5208375 Compositions for magnetic resonance imaging |
| 05/04/1993 | US5208324 Paramagnetic compounds |
| 05/04/1993 | US5207715 Method of detecting cancer by measuring lipid-peroxidation using NMR |
| 05/04/1993 | CA1317225C Use of adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery |
| 05/01/1993 | WO1993008847A1 Biological stain composition, method of preparation and method of use for delineation of epitheleal cancer |
| 04/29/1993 | WO1993008301A1 Improved method |
| 04/29/1993 | WO1993008215A1 Secreted mac-2-binding glycoprotein |
| 04/29/1993 | WO1993008122A1 Contrast agents and compositions for radiological imaging, and radiological imaging method utilizing same |
| 04/29/1993 | WO1993007907A1 Trifluoromethyl analogs for f-19 nmr imaging |
| 04/29/1993 | WO1993007905A2 Treated apatite particles for medical diagnostic imaging |
| 04/29/1993 | WO1993007888A1 Inhib, a factor which inhibits cytokine-activated leukocytes |